中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 9
Sep.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(9): 2073-2077

Features of liver function in pediatric patients infected with Delta variant versus Omicron variant of severe acute respiratory syndrome coronavirus 2

DOI: 10.3969/j.issn.1001-5256.2022.09.023

  • No. 20 Isolation Ward, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China

Research funding:

Medical Scientific Research Foundation of Guangdong Province (B2021302);

Foundation of Key Medical Disciplines in Guangzhou Gity(2021-2023)-Viral Infectious Diseases (202208XK0002)

More Information
  • Corresponding author: DENG Haohui, gz8hdhh@126.com(ORCID: 0000-0001-5948-9101)
  • Received Date: 2022-05-13
  • Accepted Date: 2022-06-15
  • Published Date: 2022-09-20
    Abstract
  •   Objective  To summarize and analyze the features of liver function in pediatric patients infected with Delta variant versus Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Methods  In this study, an analysis was performed for the liver function test results of the locally transmitted or imported pediatric patients with SARS-CoV-2 infection during isolation who were admitted to Guangzhou Eighth People's Hospital, Guangzhou Medical University, since May 21, 2021, and the clinical data and the constituent ratio of liver injury were compared between the pediatric patients infected with Delta variant and those infected with Omicron variant. The independent samples t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups.  Results  A total of 85 pediatric patients infected with SARS-CoV-2 were enrolled, among whom there were 32 (37.6%) pediatric patients infected with Delta variant and 53 (62.4%) pediatric patients infected with Omicron variant, and there were no significant differences between the two groups in age, sex, body height, body weight, and comorbidities (all P > 0.05). There were no significant differences between the two groups in alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase, total bilirubin, albumin, and cholinesterase (all P > 0.05), and the pediatric patients infected with Omicron variant had a significantly higher level of total bile acid (TBA) than those infected with Delta variant (Z=-2.336, P=0.020). However, the median values of TBA were within the normal range and the ratios of abnormal TBA were no significant difference between the two groups (P > 0.05). Among the 85 pediatric patients, 10 (11.8%) had a mild increase in liver function parameters, among whom 7 had an increase in TBA, 1 had an increase in ALT, 1 had increases in ALT and AST, and 1 had an increase in ALP. The analysis of liver injury in the pediatric patients infected with Delta variant or Omicron variant showed that there was no significant difference in the constituent ratio of liver injury caused by the two variants (6.3% vs 15.1%, χ2=0.691, P=0.406).  Conclusion  Mild liver injury is observed in pediatric patients infected with Delta and Omicron variants of SARS-CoV-2, but further studies are needed to evaluate the long-term influence of such infection on liver function.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    MARSH K, TAYLER R, POLLOCK L, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022[J]. Euro Surveill, 2022, 27(15): 2200318. DOI: 10.2807/1560-7917.ES.2022.27.15.2200318.
    [2]
    National Health Commission of the People's Republic of China. Diagnosis and treatment plan for COVID-19 (trial version 9)[J]. Inter J Epidemiol Infect Dis, 2022, 49(2): 73-80. DOI: 10.3760/cma.j.cn331340-20220325-00065.

    中国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 国际流行病学传染病学杂志, 2022, 49(2): 73-80. DOI: 10.3760/cma.j.cn331340-20220325-00065.
    [3]
    American College of Clinical Pharmacy. Reference values for common laboratory tests[EB/OL]. https://www.accp.com/docs/sap/Lab_values_Table_PedSAP.pdf.
    [4]
    World Health Organization. Disease Outbreak News; Acute hepatitis of unknown aetiology-the United Kingdom of Great Britain and Northern Ireland (15 April 2022)[EB/OL]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON368.
    [5]
    MA K, YANG ZY, CHEN T, et al. Pay close attention to the current characteristics and development trend of severe acute hepatitis with unknown etiology in children worldwide[J]. Natl Med J China, 2022, 102(20): 1429-1432. DOI: 10.3760/cma.j.cn112137-20220505-00986.

    马科, 杨中原, 陈韬, 等. 高度关注当前全球多国不明原因儿童严重急性肝炎的特征及发展动向[J]. 中华医学杂志, 2022, 102(20): 1429-1432. DOI: 10.3760/cma.j.cn112137-20220505-00986.
    [6]
    RONAN BA, AGRWAL N, CAREY EJ, et al. Fulminant hepatitis due to human adenovirus[J]. Infection, 2014, 42(1): 105-111. DOI: 10.1007/s15010-013-0527-7.
    [7]
    KAWASHIMA N, MURAMATSU H, OKUNO Y, et al. Fulminant adenovirus hepatitis after hematopoietic stem cell transplant: Retrospective real-time PCR analysis for adenovirus DNA in two cases[J]. J Infect Chemother, 2015, 21(12): 857-863. DOI: 10.1016/j.jiac.2015.08.018.
    [8]
    BOETTLER T, CSERNALABICS B, SALIÉ H, et al. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis[J]. J Hepatol, 2022. DOI: 10.1016/j.jhep.2022.03.040.[Online ahead of print]
    [9]
    ZHU Z, MAO NY, ZHANG Y, et al. Consideration on the emerging of severe acute hepatitis cases with of unknown etiology in children worldwide[J]. Chin J Prevent Med, 2022, 56(6): 679-681. DOI: 10.3760/cma.j.cn112150-20220427-00423.

    朱贞, 毛乃颖, 张燕, 等. 对当前全球部分国家出现的不明原因儿童急性严重肝炎病例的思考[J]. 中华预防医学杂志, 2022, 56(6): 679-681. DOI: 10.3760/cma.j.cn112150-20220427-00423.
    [10]
    LIN HW, LEI Y, CHEN BB, et al. Clinical features of patients with severe acute respiratory syndrome coronavirus 2 Delta variant infection and abnormal liver function in Guangdong Province, China[J]. J Clin Hepatol, 2022, 38(3): 582-586. DOI: 10.3969/j.issn.1001-5256.2022.03.017.

    林浩炜, 雷燕, 陈彬彬, 等. 广东地区新型冠状病毒Delta变异株感染并发肝功能异常患者的临床特征分析[J]. 临床肝胆病杂志, 2022, 38(3): 582-586. DOI: 10.3969/j.issn.1001-5256.2022.03.017.
    [11]
    EKPANYAPONG S, BUNCHORNTAVAKUL C, REDDY KR. COVID-19 and the liver: Lessons learnt from the EAST and the WEST, a year later[J]. J Viral Hepat, 2022, 29(1): 4-20. DOI: 10.1111/jvh.13590.
    [12]
    HUANG YK, LI YJ, LI B, et al. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives[J]. World J Gastroenterol, 2021, 27(27): 4358-4370. DOI: 10.3748/wjg.v27.i27.4358.
    [13]
    VIANA R, MOYO S, AMOAKO DG, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa[J]. Nature, 2022, 603(7902): 679-686. DOI: 10.1038/s41586-022-04411-y.
    [14]
    ADAM D. What scientists know about new, fast-spreading coronavirus variants[J]. Nature, 2021, 594(7861): 19-20. DOI: 10.1038/d41586-021-01390-4.
    [15]
    DENG H, LIN H, MAI Y, et al. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients[J]. Eur J Gastroenterol Hepatol, 2022. DOI: 10.1097/MEG.0000000000002381.[Online ahead of print]
    [16]
    CHAI XQ, HU LF, ZHANG Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection[J]. bioRxiv, 2020. DOI: 10.1101/2020.02.03.931766.[Online ahead of print]
    [17]
    BRODIN P, ARDITI M. Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens[J]. Lancet Gastroenterol Hepatol, 2022, 7(7): 594-595. DOI: 10.1016/S2468-1253(22)00166-2.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (431) PDF downloads(29) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return